Prostaglandin D₂ in the skinIKAI, K; IMAMURA, S.International journal of dermatology. 1988, Vol 27, Num 3, pp 141-149, issn 0011-9059Article

The biology and pharmacology of PGD₂GILES, H; LEFF, P.Prostaglandins. 1988, Vol 35, Num 2, pp 277-300, issn 0090-6980Article

Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptorWALLACE, R. A; TAHIRA FAROOQUI; WALLACE, L et al.Biochemical pharmacology. 1987, Vol 36, Num 22, pp 3903-3910, issn 0006-2952Article

Absorption, metabolism, and excretion of [¹⁴C]MK-0524, a prostaglandin D₂ receptor antagonist, in humansKARANAM, Bindhu; MADEIRA, Maria; GARRETT, Graigory et al.Drug metabolism and disposition. 2007, Vol 35, Num 7, pp 1196-1202, issn 0090-9556, 7 p.Article

PharmGKB summary: dopamine receptor D2HUAIYU MI; THOMAS, Paul D; RING, Huijun Z et al.Pharmacogenetics and genomics (Print). 2011, Vol 21, Num 6, pp 350-356, issn 1744-6872, 7 p.Article

Identification and characterization of two nuclear factor-κB sites in the regulatory region of the dopamine D2 receptorBONTEMPI, Sandra; FIORENTINI, Chiara; BUSI, Chiara et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 5, pp 2563-2570, issn 0013-7227, 8 p.Article

Putative mechanism of the itch-scratch circle : Repeated scratching decreases the cutaneous level of prostaglandin D₂, a mediator that inhibits itchingSUGIMOTO, Masanori; ARAI, Iwao; FUTAKI, Nobuko et al.Prostaglandins, leukotrienes and essential fatty acids. 2007, Vol 76, Num 2, pp 93-101, issn 0952-3278, 9 p.Article

Dopamine D₂-Like Receptor in the Nucleus Accumbens Is Involved in the Antinociceptive Effect of Nitrous OxideKOYANAGI, Sahoko; HIMUKASHI, Shugaku; MUKAIDA, Kumiko et al.Anesthesia and analgesia. 2008, Vol 106, Num 6, pp 1904-1909, issn 0003-2999, 6 p.Article

The D₂ receptor : an inhibitory receptor which can trigger stimulatory responsesVALLAR, L; MUCA, C; CIVELLI, O et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 197S-200S, issn 0197-0186, SUPConference Paper

Preferential production of prostaglandin D₂ by lipopolysaccharide stimulated human choriodecidual explantsSATO, Timothy A; MITCHELL, Murray D.Prostaglandins, leukotrienes and essential fatty acids. 2006, Vol 74, Num 2, pp 87-92, issn 0952-3278, 6 p.Article

Biochemical studies on D₂-dopamine receptorsSTRANGE, P. G.Neurochemistry international. 1992, Vol 20, Num MAR, pp 59S-62S, issn 0197-0186, SUPConference Paper

Association of DRD2 gene variant with schizophreniaKUKRETI, Ritushree; TRIPATHI, Sudipta; BHATNAGAR, Pallav et al.Neuroscience letters. 2006, Vol 392, Num 1-2, pp 68-71, issn 0304-3940, 4 p.Article

The prostaglandin D₂ receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challengeRUI HE; OYOSHI, Michiko K; WANG, James Y. T et al.Journal of allergy and clinical immunology. 2010, Vol 126, Num 4, pp 784-790, issn 0091-6749, 7 p.Article

¹²⁵I-spiperone: a novel ligand for D₂ dopamine receptorsGUNDLACH, A. L; LARGENT, B. L; SNYDER, S. H et al.Life sciences (1973). 1984, Vol 35, Num 19, pp 1981-1988, issn 0024-3205Article

Interaction between prostaglandin D₂ and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cellsXUE, L; BARROW, A; PETTIPHER, R et al.Clinical and experimental immunology (Print). 2009, Vol 156, Num 1, pp 126-133, issn 0009-9104, 8 p.Article

Dopamine D₂ receptor subtypes couple to different second messenger systemsTODD, R. D; MACK, K. J; GANDELMAN, K.-Y et al.Neurochemistry international. 1992, Vol 20, Num MAR, pp 23S-26S, issn 0197-0186, SUPConference Paper

Influence of the dopamine D₂ receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawalLUCHT, Michael J; KUEHN, Kail U; FREYBERGER, Harald J et al.Pharmacogenetics (London). 2001, Vol 11, Num 8, pp 647-653, issn 0960-314XArticle

The effect of prostaglandin D₂ on angiotensin converting enzymeRAO, P. S; CAVANAGH, D; O'BRIEN, W. F et al.Prostaglandins, leukotrienes and essential fatty acids. 1988, Vol 33, Num 2, pp 111-114, issn 0952-3278Article

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D₂ receptor subtype 1LAI, E; DE LEPELEIRE, I; CRUMLEY, T. M et al.Clinical pharmacology and therapeutics. 2007, Vol 81, Num 6, pp 849-857, issn 0009-9236, 9 p.Article

Solubilization of dopamine-D₂receptors from synaptosomal membranes of the bovine caudate nucleusKIDRIC, M; PETROVIC, J; SOSKIC, V et al.British journal of pharmacology. 1984, Vol 83, Num 3, pp 687-695, issn 0007-1188Article

Quantification of thromboxane and PGD₂ metabolites in biological fluidsJACKSON ROBERTS II, L; OATES, J. A.Prostaglandins. 1984, Vol 27, Num 3, pp 352-354, issn 0090-6980Article

Decreased number of PGD₂ binding sites on platelets from patients with type IIa hyperlipoproteinemiaABBATE, R; MODESTI, P. A; FORTINI, A et al.Atherosclerosis. 1985, Vol 54, Num 2, pp 167-175, issn 0021-9150Article

The opposing role of two prostaglandin D₂ receptors, DP and CRTH2, in human eosinophil migrationCHIBA, Takahito; UEKI, Shigeharu; ITO, Wataru et al.Annals of allergy, asthma, & immunology. 2011, Vol 106, Num 6, pp 511-517, issn 1081-1206, 7 p.Article

The ternary complex model: its properties and application to ligand interactions with the D₂-dopamine receptor of the anterior pituitary glandWREGGETT, K. A; DE LEAN, A.Molecular pharmacology. 1984, Vol 26, Num 2, pp 214-227, issn 0026-895XArticle

Metabolism of MK-0524, a prostaglandin D₂ receptor 1 antagonist, in microsomes and hepatocytes from preclinical species and humansDEAN, Brian J; CHANG, Steve; SILVA ELIPE, Maria Victoria et al.Drug metabolism and disposition. 2007, Vol 35, Num 2, pp 283-292, issn 0090-9556, 10 p.Article